Evanthia T. Roussos-Torres Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine University of Southern California Biography Publications Institution JoVE Articles Evanthia T. Roussos-Torres has not added a biography. If you are Evanthia T. Roussos-Torres and would like to personalize this page please email our Author Liaison for assistance. Publications Neurotransmitter Signaling: a New Frontier in Colorectal Cancer Biology and Treatment Oncogene. 10, 2022 | Pubmed ID: 36182970 Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment Cancer Immunology Research. 05, 2022 | Pubmed ID: 35201318 Emerging Combination Immunotherapy Strategies for Breast Cancer: Dual Immune Checkpoint Modulation, Antibody-drug Conjugates and Bispecific Antibodies Breast Cancer Research and Treatment. Jan, 2022 | Pubmed ID: 34716871 Evaluating the Impact of Age on Immune Checkpoint Therapy Biomarkers Cell Reports. 08, 2021 | Pubmed ID: 34433020 Lymph Node Immune Profiles As Predictive Biomarkers for Immune Checkpoint Inhibitor Response Frontiers in Molecular Biosciences. 2021 | Pubmed ID: 34141724 Phase I Study of Entinostat and Nivolumab with or Without Ipilimumab in Advanced Solid Tumors (ETCTN-9844) Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 11, 2021 | Pubmed ID: 34135021 Clocking Cancer: the Circadian Clock As a Target in Cancer Therapy Oncogene. 05, 2021 | Pubmed ID: 33846572 Adopting an Alternative Structure for Clinical Trials in Immunotherapy Expert Review of Anticancer Therapy. 04, 2021 | Pubmed ID: 33435760 Regulation of the Tumor Immune Microenvironment and Vascular Normalization in TNBC Murine Models by a Novel Peptide Oncoimmunology. 05, 2020 | Pubmed ID: 32923118 Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach JCO Oncology Practice. Oct, 2020 | Pubmed ID: 32603252 Best Foot Forward: Neoadjuvant Systemic Therapy As Standard of Care in Triple-Negative and HER2-Positive Breast Cancer American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. Mar, 2020 | Pubmed ID: 32315235 継代なしの正常および腫瘍乳腺組織からのマウスおよびヒト上皮オルガノイドの生成とイメージング Serena L. Cornelius1,2, Megan M. Colonnetta2,3,4,5, Katherine E. Lake1,2, Clayton A. Smith1,2, Yu-An Zhang1,2, Evanthia T. Roussos-Torres6, Sangeetha M. Reddy1,2, Elizabeth H. Chen2,3,4,5, Isaac S. Chan1,2,3,4 1Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, 2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 3Department of Molecular Biology, University of Texas Southwestern Medical Center, 4Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, 5Department of Cell Biology, University of Texas Southwestern Medical Center, 6Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California JoVE 64626 Cancer Research
継代なしの正常および腫瘍乳腺組織からのマウスおよびヒト上皮オルガノイドの生成とイメージング Serena L. Cornelius1,2, Megan M. Colonnetta2,3,4,5, Katherine E. Lake1,2, Clayton A. Smith1,2, Yu-An Zhang1,2, Evanthia T. Roussos-Torres6, Sangeetha M. Reddy1,2, Elizabeth H. Chen2,3,4,5, Isaac S. Chan1,2,3,4 1Department of Internal Medicine, Division of Hematology and Oncology, University of Texas Southwestern Medical Center, 2Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 3Department of Molecular Biology, University of Texas Southwestern Medical Center, 4Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, 5Department of Cell Biology, University of Texas Southwestern Medical Center, 6Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California JoVE 64626 Cancer Research
